Recall Atlas
Drugs & medical

Recall of one lot of JAMP Guanfacine XR 4 mg tablets due to contamination with foreign matter

Contamination - Product safety

Read the official notice →
Date
2024-04-12
Country
Canada
Product
JAMP-Guanfacine XR 4 mg tablets
Category
Drugs & medical
Source
Health Canada

Copied automatically from the Government of Canada. Details may be shortened or out of date; the official notice is the authoritative source. Disclaimer

What to do

  1. Check the product name, strength and lot number against the official notice.
  2. Do not stop a prescribed medicine without talking to your doctor or pharmacist first.
  3. Ask the pharmacy or supplier about a replacement or refund.

General guidance from Recall Atlas. The official notice from the Government of Canada has the exact models, batch codes and remedy, and it takes priority.

Other drugs & medical recalls in Canada

  1. 2024-04-17
  2. CA
    Drugs & medicalType I

    PMS-Duloxetine 30 mg: Exceeds acceptable interim intake limit for N-nitroso-duloxetine (NDLX)

    Product quality

    Health CanadaOfficial notice →
  3. 2024-04-16
  4. CA
    Drugs & medicalType II

    Rheo Knee and Rheo Knee XC

    Performance

    Health CanadaOfficial notice →
  5. CA
    Drugs & medicalType II

    Universal Viewer

    Performance

    Health CanadaOfficial notice →
  6. 2024-04-11
  7. CA
    Drugs & medicalType II

    RayStation

    Performance

    Health CanadaOfficial notice →
  8. CA
    Drugs & medicalType II

    Dako Coverstainers

    Performance

    Health CanadaOfficial notice →
  9. CA
    Drugs & medicalType II

    Blood Pressure Unit

    Performance

    Health CanadaOfficial notice →
See all drugs & medical recalls →